A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 105 (4), 704-710
- https://doi.org/10.1067/mai.2000.105123
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The value of acoustic rhinometry in assessing nasal responses to cat exposureJournal of Allergy and Clinical Immunology, 1998
- Cat antigen in homes with and without cats may induce allergic symptomsJournal of Allergy and Clinical Immunology, 1996
- The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis.American Journal of Respiratory and Critical Care Medicine, 1995
- The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmaticsEuropean Respiratory Journal, 1994
- The aerodynamic characteristics of cat allergenClinical and Experimental Allergy, 1993
- Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthmaJournal of Allergy and Clinical Immunology, 1992
- Role of Leukotrienes in Exercise-induced Asthma: Inhibitory Effect of ICI 204219, a Potent Leukotriene D4Receptor AntagonistAmerican Review of Respiratory Disease, 1992
- Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsThe Lancet, 1991
- Acoustic rhinometry: evaluation of nasal cavity geometry by acoustic reflectionJournal of Applied Physiology, 1989
- Standardization of bronchial inhalation challenge proceduresJournal of Allergy and Clinical Immunology, 1975